Search by Drug Name or NDC
NDC 00832-1425-10 Brimonidine Tartrate and Timolol Maleate 2; 5 mg/mL; mg/mL Details
Brimonidine Tartrate and Timolol Maleate 2; 5 mg/mL; mg/mL
Brimonidine Tartrate and Timolol Maleate is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Upsher-Smith Laboratories, LLC. The primary component is BRIMONIDINE TARTRATE; TIMOLOL MALEATE.
Product Information
NDC | 00832-1425 |
---|---|
Product ID | 0832-1425_7aa410f8-a849-49e1-a670-11114d7c003e |
Associated GPIs | |
GCN Sequence Number | 053407 |
GCN Sequence Number Description | brimonidine tartrate/timolol DROPS 0.2%-0.5% OPHTHALMIC |
HIC3 | Q6G |
HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
GCN | 20876 |
HICL Sequence Number | 025804 |
HICL Sequence Number Description | BRIMONIDINE TARTRATE/TIMOLOL MALEATE |
Brand/Generic | Generic |
Proprietary Name | Brimonidine Tartrate and Timolol Maleate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Brimonidine Tartrate and Timolol Maleate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SOLUTION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 2; 5 |
Active Ingredient Units | mg/mL; mg/mL |
Substance Name | BRIMONIDINE TARTRATE; TIMOLOL MALEATE |
Labeler Name | Upsher-Smith Laboratories, LLC |
Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Antagonists [MoA], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Blocker [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA215598 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00832-1425-10 (00832142510)
NDC Package Code | 0832-1425-10 |
---|---|
Billing NDC | 00832142510 |
Package | 1 BOTTLE, DROPPER in 1 CARTON (0832-1425-10) / 10 mL in 1 BOTTLE, DROPPER |
Marketing Start Date | 2023-01-09 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 14.3511 |
Pricing Unit | ML |
Effective Date | 2024-02-21 |
NDC Description | BRIMONIDINE-TIMOLOL 0.2%-0.5% |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis